Gradient Investments LLC Takes Position in Teleflex Incorporated (TFX)
Gradient Investments LLC purchased a new position in Teleflex Incorporated (NYSE:TFX) during the fourth quarter, HoldingsChannel.com reports. The institutional investor purchased 1,265 shares of the medical technology company’s stock, valued at approximately $315,000.
A number of other large investors have also modified their holdings of the business. Stifel Financial Corp boosted its stake in Teleflex by 0.6% in the 2nd quarter. Stifel Financial Corp now owns 5,399 shares of the medical technology company’s stock worth $1,121,000 after buying an additional 31 shares during the last quarter. Toronto Dominion Bank boosted its stake in Teleflex by 14.5% in the 2nd quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock worth $115,000 after buying an additional 70 shares during the last quarter. Comerica Bank boosted its stake in Teleflex by 0.6% in the 4th quarter. Comerica Bank now owns 35,546 shares of the medical technology company’s stock worth $9,778,000 after buying an additional 198 shares during the last quarter. Chartwell Investment Partners LLC boosted its stake in Teleflex by 3.9% in the 3rd quarter. Chartwell Investment Partners LLC now owns 5,444 shares of the medical technology company’s stock worth $1,317,000 after buying an additional 204 shares during the last quarter. Finally, Creative Planning boosted its stake in Teleflex by 6.0% in the 4th quarter. Creative Planning now owns 4,119 shares of the medical technology company’s stock worth $1,025,000 after buying an additional 234 shares during the last quarter. 89.22% of the stock is currently owned by hedge funds and other institutional investors.
A number of analysts have issued reports on the company. Leerink Swann reissued a “buy” rating and issued a $321.00 price target (up from $307.00) on shares of Teleflex in a research note on Tuesday, January 30th. Morgan Stanley raised their price target on Teleflex from $274.00 to $290.00 and gave the stock an “equal weight” rating in a research note on Friday, November 3rd. Stephens reissued a “buy” rating and issued a $300.00 price target on shares of Teleflex in a research note on Thursday, January 18th. ValuEngine lowered Teleflex from a “buy” rating to a “hold” rating in a research note on Friday, December 1st. Finally, Piper Jaffray Companies initiated coverage on Teleflex in a report on Friday, November 10th. They issued an “overweight” rating and a $295.00 price objective on the stock. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating and six have given a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $283.89.
In related news, Director George Babich, Jr. sold 2,500 shares of the firm’s stock in a transaction dated Monday, February 12th. The stock was sold at an average price of $252.57, for a total transaction of $631,425.00. Following the sale, the director now directly owns 10,259 shares in the company, valued at approximately $2,591,115.63. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Stephen K. M.D. Klasko sold 200 shares of the firm’s stock in a transaction dated Friday, December 1st. The shares were sold at an average price of $265.32, for a total value of $53,064.00. Following the sale, the director now owns 8,080 shares in the company, valued at $2,143,785.60. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 10,100 shares of company stock worth $2,671,994. Company insiders own 2.39% of the company’s stock.
ILLEGAL ACTIVITY NOTICE: This report was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this report on another website, it was illegally stolen and republished in violation of U.S. and international copyright and trademark laws. The legal version of this report can be accessed at https://www.thecerbatgem.com/2018/02/14/gradient-investments-llc-takes-position-in-teleflex-incorporated-tfx.html.
Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).
Want to see what other hedge funds are holding TFX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Teleflex Incorporated (NYSE:TFX).
Receive News & Ratings for Teleflex Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex and related companies with MarketBeat.com's FREE daily email newsletter.